Alan Scott Enterprises Ltd
Incorporated in 1994, Alan Scott Industries manufacture health and hygiene products for use in hospitals and homes
- Market Cap ₹ 150 Cr.
- Current Price ₹ 276
- High / Low ₹ 345 / 92.0
- Stock P/E
- Book Value ₹ 14.9
- Dividend Yield 0.00 %
- ROCE -14.2 %
- ROE -142 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 18.6 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -127% over last 3 years.
- Earnings include an other income of Rs.2.25 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0.02 | 1.24 | 5.17 | 11.42 | 28.69 | 34.00 | |
| 0.11 | 1.90 | 5.60 | 11.47 | 26.75 | 31.45 | |
| Operating Profit | -0.09 | -0.66 | -0.43 | -0.05 | 1.94 | 2.55 |
| OPM % | -450.00% | -53.23% | -8.32% | -0.44% | 6.76% | 7.50% |
| 0.09 | 0.67 | 0.06 | 0.35 | 2.25 | 2.25 | |
| Interest | 0.00 | 0.02 | 0.61 | 1.38 | 2.20 | 2.58 |
| Depreciation | 0.00 | 0.05 | 1.08 | 2.41 | 3.80 | 3.89 |
| Profit before tax | 0.00 | -0.06 | -2.06 | -3.49 | -1.81 | -1.67 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | ||
| 0.00 | -0.07 | -2.06 | -3.50 | -1.82 | -1.68 | |
| EPS in Rs | 0.00 | -0.11 | -3.50 | -6.48 | -3.37 | -1.96 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 185% |
| TTM: | 61% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 67% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 90% |
| 3 Years: | 94% |
| 1 Year: | 130% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -127% |
| Last Year: | -142% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.19 | 1.83 | 1.83 | 3.62 | 3.63 | 5.45 |
| Reserves | 0.35 | 1.25 | -0.64 | -0.26 | -1.86 | 2.65 |
| 0.05 | 0.17 | 3.00 | 8.62 | 7.38 | 11.72 | |
| 0.00 | 2.32 | 6.20 | 15.87 | 18.10 | 15.55 | |
| Total Liabilities | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.37 |
| 0.00 | 2.60 | 6.01 | 15.03 | 15.82 | 16.96 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59 |
| Investments | 0.30 | 0.21 | 0.21 | 0.89 | 1.36 | 2.94 |
| 1.29 | 2.76 | 4.17 | 11.93 | 10.07 | 13.88 | |
| Total Assets | 1.59 | 5.57 | 10.39 | 27.85 | 27.25 | 35.37 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0.18 | -1.58 | -2.78 | -3.11 | -1.68 | |
| -0.21 | -0.95 | 0.31 | -3.05 | 0.10 | |
| 1.29 | 1.73 | 2.15 | 8.53 | -0.15 | |
| Net Cash Flow | 1.26 | -0.80 | -0.33 | 2.37 | -1.74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 0.00 | 2.94 | 0.71 | 13.10 | 7.89 |
| Inventory Days | 124.03 | 227.11 | 211.75 | 88.66 | |
| Days Payable | 88.59 | 107.76 | 126.84 | 15.87 | |
| Cash Conversion Cycle | 0.00 | 38.38 | 120.06 | 98.01 | 80.68 |
| Working Capital Days | -730.00 | 73.59 | -46.60 | -70.63 | 26.33 |
| ROCE % | -27.63% | -35.79% | -26.39% | -14.21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Director
14 Nov - Approved Q1 results; acquired 60% of Alanscott Qubiverse for INR 3,00,000; director appointment and resignation on Nov 13, 2025.
-
Announcement under Regulation 30 (LODR)-Acquisition
14 Nov - Approved Q2 (Sept 30, 2025) results; acquired 60% of AQL for INR 3,00,000; director changes Nov 13, 2025.
-
Revised Outcome Of Board Meeting Held On Thursday, November 13, 2025 At 11:15 AM (IST) Through Video Conferencing ('VC'). Reference: Additional Details Required For Corporate Announcement Filed Under
Regulation 30 Of SEBI (LODR) Regulations, 2015
14 Nov - Approved Q2 results; acquired 60% of AQL for INR 3,00,000; director resignation and appointment on Nov 13, 2025.
-
Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended September 30, 2025.
13 Nov - No deviation in utilization of INR 726.34 Lakhs rights issue proceeds (18,15,863 shares), quarter ended Sep 30, 2025.
- Results - Unaudited Standalone And Consolidated Results For The Quarter Ended Septemebr 30, 2025 13 Nov
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2006
from bse
-
Financial Year 2005
from bse
Product Profile:
a) 5 petals AIR purifier+[1]
This uses 8 different technologies instead of 5 certified technologies to provide protection from aerosol spread of 99.9% of Virus, Bacteria, fungus and Yeasts
b) 5 Petals O2 Concentrator[2]
It's a supplement of oxygen with a capacity
of 8-25 LPM and a High Purity Oxygen 90-95%
Clientele:[3]
Larsen & Tubro, Som Capital, Rubix,
Thought Bridge HR, Verstech, Sunicon, Sanjivani Parentrals3